Roxane Hervé

567 total citations
17 papers, 449 citations indexed

About

Roxane Hervé is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Roxane Hervé has authored 17 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Roxane Hervé's work include Eosinophilic Esophagitis (3 papers), IL-33, ST2, and ILC Pathways (3 papers) and Preterm Birth and Chorioamnionitis (3 papers). Roxane Hervé is often cited by papers focused on Eosinophilic Esophagitis (3 papers), IL-33, ST2, and ILC Pathways (3 papers) and Preterm Birth and Chorioamnionitis (3 papers). Roxane Hervé collaborates with scholars based in France, Germany and Tunisia. Roxane Hervé's co-authors include Natacha Bessis, Marie‐Christophe Boissier, Delphine Lemeiter, Clotilde Duquenne, D. Cabrol, Ronan Le Bouffant, René Habert, Benoît Souquet, Thomas Schmitz and Gabriel Livéra and has published in prestigious journals such as The Journal of Immunology, Development and Frontiers in Immunology.

In The Last Decade

Roxane Hervé

15 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roxane Hervé France 12 189 170 89 75 57 17 449
Sonia T. Chelbi France 18 341 1.8× 276 1.6× 38 0.4× 54 0.7× 78 1.4× 24 892
Saori Otsuka Japan 14 215 1.1× 116 0.7× 57 0.6× 22 0.3× 70 1.2× 30 522
Xiaoyin Lu China 16 376 2.0× 250 1.5× 75 0.8× 45 0.6× 52 0.9× 20 850
Krassimira Todorova Bulgaria 13 204 1.1× 178 1.0× 56 0.6× 36 0.5× 36 0.6× 36 437
Tracy Niven‐Fairchild United States 11 228 1.2× 260 1.5× 222 2.5× 68 0.9× 40 0.7× 11 659
Soren Hayrabedyan Bulgaria 14 160 0.8× 220 1.3× 75 0.8× 39 0.5× 26 0.5× 38 464
Valerie Fock Austria 12 179 0.9× 230 1.4× 52 0.6× 60 0.8× 22 0.4× 16 525
Karen Agnew New Zealand 11 50 0.3× 136 0.8× 58 0.7× 63 0.8× 24 0.4× 19 387
M. Kadyrov Germany 7 103 0.5× 181 1.1× 34 0.4× 51 0.7× 22 0.4× 13 485
Elma El Khouri France 9 147 0.8× 66 0.4× 27 0.3× 40 0.5× 36 0.6× 13 295

Countries citing papers authored by Roxane Hervé

Since Specialization
Citations

This map shows the geographic impact of Roxane Hervé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxane Hervé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxane Hervé more than expected).

Fields of papers citing papers by Roxane Hervé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxane Hervé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxane Hervé. The network helps show where Roxane Hervé may publish in the future.

Co-authorship network of co-authors of Roxane Hervé

This figure shows the co-authorship network connecting the top 25 collaborators of Roxane Hervé. A scholar is included among the top collaborators of Roxane Hervé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxane Hervé. Roxane Hervé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hervé, Roxane, Luca Semerano, Natacha Bessis, et al.. (2025). Intra-articular sustained-release colchicine is efficacious in an inflammatory arthritis rat model. RMD Open. 11(3). e005988–e005988.
2.
Lemeiter, Delphine, Roxane Hervé, Gaëlle Clavel, et al.. (2024). Impairment of regulatory T cell stability in axial spondyloarthritis: role of EZH2 and pSTAT5. Frontiers in Immunology. 15. 1484321–1484321. 1 indexed citations
4.
Pezet, Sonia, Anne Cauvet, Julie Pires Da Silva, et al.. (2020). Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis. Annals of the Rheumatic Diseases. 79(7). 891–900. 19 indexed citations
5.
Biton, Jérôme, Gaëlle Clavel, Roxane Hervé, et al.. (2019). Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis. Arthritis & Rheumatology. 72(4). 576–587. 32 indexed citations
6.
Athari, Seyyed Shamsadin, Jérôme Biton, Luca Semerano, et al.. (2016). Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33. Arthritis Research & Therapy. 18(1). 143–143. 22 indexed citations
7.
Biton, Jérôme, Seyyed Shamsadin Athari, Allan Thiolat, et al.. (2016). In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis. The Journal of Immunology. 197(5). 1708–1719. 47 indexed citations
8.
Perez, Joëlle, Roxane Hervé, Houda Tamouza, et al.. (2015). Calpains Released by T Lymphocytes Cleave TLR2 To Control IL-17 Expression. The Journal of Immunology. 196(1). 168–181. 23 indexed citations
9.
Thiolat, Allan, Anne Denys, Marie Petit, et al.. (2014). Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice. Cytokine. 69(1). 87–93. 43 indexed citations
10.
Biton, Jérôme, Allan Thiolat, Seyyed Shamsadin Athari, et al.. (2014). 1.64 Interleukin-33 suppresses experimental arthritis through promoting Foxp3+ regulatory T-cells and type-2 immune responses in mice. Annals of the Rheumatic Diseases. 73. A28–A28. 1 indexed citations
11.
Souquet, Benoît, Emilie Abby, Roxane Hervé, et al.. (2013). MEIOB Targets Single-Strand DNA and Is Necessary for Meiotic Recombination. PLoS Genetics. 9(9). e1003784–e1003784. 91 indexed citations
12.
Bouffant, Ronan Le, Benoît Souquet, Nathalie Duval, et al.. (2011). Msx1 and Msx2 promote meiosis initiation. Development. 138(24). 5393–5402. 55 indexed citations
13.
Hervé, Roxane, Thomas Schmitz, Danièle Evain‐Brion, et al.. (2008). The PDE4 Inhibitor Rolipram Prevents NF-κB Binding Activity and Proinflammatory Cytokine Release in Human Chorionic Cells. The Journal of Immunology. 181(3). 2196–2202. 26 indexed citations
14.
Schmitz, Thomas, Evelyne Souil, Roxane Hervé, et al.. (2007). PDE4 Inhibition Prevents Preterm Delivery Induced by an Intrauterine Inflammation. The Journal of Immunology. 178(2). 1115–1121. 50 indexed citations
15.
Méhats, Céline, Thomas Schmitz, S. Oger, et al.. (2007). PDE4 as a target in preterm labour. BMC Pregnancy and Childbirth. 7(S1). S12–S12. 22 indexed citations
16.
Bernard, O, et al.. (2003). [Cylindroma of the trachea, a rate tumor with unusual evolution].. PubMed. 32(13 Pt 1). 602–602. 1 indexed citations
17.
Robinet, Éric, et al.. (1999). Préparation de produits de thérapie cellulaire: apport des systèmes clos. Transfusion Clinique et Biologique. 6(6). 409–417. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026